Fertility warning
This medicine may affect fertility.
Leaflet PAZOPANIB ADALVO 200mg film-coated tablets
Precautions:
Cytotoxic / special handling
Handle with special care.
Contraception required
Effective contraception is required during treatment.
Contraindicated during breastfeeding
Do not use this medicine while breastfeeding.
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Avoid grapefruit
Avoid grapefruit and grapefruit juice.
Hepatotoxicity
This medicine may affect the liver.
Major drug interactions
This medicine may have important interactions with other medicines.
Myelosuppression / agranulocytosis
This medicine may lower blood cell counts.
Additional monitoring
This medicine is subject to additional monitoring.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Severe skin reactions
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Cardiac risk / QT prolongation / arrhythmias
This medicine may increase the risk of heart rhythm disturbances.
Pazopanib is a medication used for the treatment of certain types of cancer, such as advanced renal cell carcinoma and soft tissue sarcoma. It is a tyrosine kinase inhibitor that blocks the growth of blood vessels supplying tumors, thereby slowing cancer progression.
The medication is taken orally, usually once daily, and should be used as directed by your doctor. Regular check-ups are important to monitor the effectiveness of the treatment and any potential side effects.
Side effects may include nausea, diarrhea, high blood pressure, fatigue, or changes in liver function. In rare cases, severe reactions such as liver failure or bleeding may occur.
Patients should inform their doctor about any other medications being used or pre-existing conditions to ensure the safe use of pazopanib.
The medication is taken orally, usually once daily, and should be used as directed by your doctor. Regular check-ups are important to monitor the effectiveness of the treatment and any potential side effects.
Side effects may include nausea, diarrhea, high blood pressure, fatigue, or changes in liver function. In rare cases, severe reactions such as liver failure or bleeding may occur.
Patients should inform their doctor about any other medications being used or pre-existing conditions to ensure the safe use of pazopanib.
General data about PAZOPANIB ADALVO 200mg
- Substance:
- pazopanib
- Date of latest medicines list:
- 01-09-2021
- Product code:
- W67887001
- Concentration:
- 200mg
- Pharmaceutical form:
- film-coated tablets
- Quantity:
- 30
- Product type:
- Generic medicine
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.